AminoChain employee Amira Bouguera is participating in the Agents, Everywhere: Bots, Channels, & More Global Hackathon in Paris.

AminoChain transforms static patient cohorts into dynamic, longitudinal research networks. We help pharmaceutical and biotechnology companies, research institutions, and patient organizations build research programs that continue creating value long after the first participant enrolls. Our integrated platform combines participant recruitment, eConsent, cohort management, biospecimen collection, health record integration, molecular data generation, and longitudinal participant engagement in one place. Rather than consenting participants once and losing contact, AminoChain enables ongoing follow-up, recontact, reconsent, repeat sampling, and participation in future research and clinical trials. Our platform includes an IRB-approved master protocol, the Donor Portal for participant engagement, the Donor Management System (DOMS) for study operations, and laboratory and biorepository capabilities to support research from study activation through long-term follow-up. The result is faster recruitment, stronger participant retention, richer clinical and molecular datasets, and research cohorts that become more valuable over time. AminoChain helps researchers accelerate biomarker discovery, translational research, and therapeutic development while reducing the operational complexity of building and managing longitudinal studies. We believe research works best when participants remain connected to the science they make possible. By building lasting relationships between participants, research sites, and sponsors, AminoChain is helping build the next generation of precision medicine.